Immuna is a for-profit, mission-driven enterprise that helps hospitals deliver CAR-T and gene therapies through decentralized manufacturing, regulatory support, and shared value so clinicians can focus purely on patients.
Immuna aims to bring technological neutrality, regulatory trust, and operational simplicity to the next generation of cell- and gene-based advanced therapies as a for-profit, mission-driven entity.
Our model is inspired by global pioneers who have shown that decentralized manufacturing and local capacity can make advanced therapies more accessible worldwide.
Core Mission: Enable every qualified hospital or clinician to deliver cell and gene therapy without worrying about non-clinical burdens.
Immuna handles the full non-clinical stack from infrastructure to compliance to revenue sharing , so clinicians and hospitals can focus purely on patient outcomes.
+41 79 889 81 63
Platform for B-cell malignancies
Integrated into hospitals and regional hubs
(Build–Own–Operate–Transfer)
Across Switzerland, India, Indonesia, Africa, GCC, Central Asia & Caribbean
Where transformative therapies and proven manufacturing expertise finally converge—for your patients, your research, and the world.
Boro Dropulic
Boro holds a PhD from the University of Western Australia and an MBA from the Johns Hopkins University (JHU). He has been involved in gene therapy since the late 1980s.
Seeing a need for improved business models to support the affordability and accessibility of gene therapy products, Boro co-founded Caring Cross and serves as our Executive Director.
Pradeep Kakkattil
Global health and innovations leader. Co-founder of Health Innovation Exchange (HIEx) a unique platform connecting political leadership with innovators and investors for healthcare access which over last 2 years has facilitated over US200m in investments;
Co-founder of the Women in Innovation Fund (WiNFUND) which advocates, invests and supports acceleration of female health entrepreneurship in Africa and Asia;
Co-founder of Technical Support Facility (TSF) and built it to be the largest TA mechanism of the UN in HIV;
Dr. Biju Jacob
Experienced leader in innovation strategy, research infrastructure and start-up advisory with a decade of experience in early-stage discovery, clinical research and regulatory affairs. Worked in both large organizations and start-ups with deep medical research & management experience.
He is a recipient of BIRAC Innovation 2014 award, ISBA National award for entrepreneurship 2010 and CV Raman Young Scientist Awards 2007
Phani Sripada
Seasoned information security leader with over a decade of experience driving strategic initiatives at the intersection of Digital Transformation, Cybersecurity, Sustainability, and Corporate Digital Responsibility (CDR). As Chief Information Security Officer at Gavi, the Vaccine Alliance, I spearhead security strategies, risk management, and compliance to protect critical systems supporting global health and immunization.